Table 3.
Open in new tab

Factors Associated With Physical Functioning and Respiratory Symptoms at the Time of Treatment Initiation

Physical FunctioningRespiratory Symptoms
Coefficient (95% CI)PCoefficient (95% CI)P
Radiographic type
 Nodular bronchiectaticReferenceReference
 Fibrocavitary−6.16 (−13.5, 1.18).100−2.44 (−7.52, 2.63).344
 Other−6.00 (−16.2, 4.22).249−4.58 (−11.7, 2.51).205
Mycobacterial species
 M. aviumReferenceReference
 M. intracellulare2.73 (−2.78, 8.25).3300.18 (−3.73, 4.08).930
 M. abscessus−2.21 (−10.4, 5.96).594−1.97 (−7.73, 3.79).501
 M. massiliense−5.15 (−14.2, 3.88).263−4.14 (−10.5, 2.26).204
 M. kansasii7.31 (−17.3, 32.0).5606.34 (−11.1, 23.8).474
Spirometry
 FEV1, L3.84 (−4.77, 12.4).3813.80 (−2.01, 9.62).199
 FVC, L9.26 (2.64, 15.9).0062.29 (−2.31, 6.90).327
 DLCO, %.23 (.08, .38).003.16 (.06, .26).001
Physical FunctioningRespiratory Symptoms
Coefficient (95% CI)PCoefficient (95% CI)P
Radiographic type
 Nodular bronchiectaticReferenceReference
 Fibrocavitary−6.16 (−13.5, 1.18).100−2.44 (−7.52, 2.63).344
 Other−6.00 (−16.2, 4.22).249−4.58 (−11.7, 2.51).205
Mycobacterial species
 M. aviumReferenceReference
 M. intracellulare2.73 (−2.78, 8.25).3300.18 (−3.73, 4.08).930
 M. abscessus−2.21 (−10.4, 5.96).594−1.97 (−7.73, 3.79).501
 M. massiliense−5.15 (−14.2, 3.88).263−4.14 (−10.5, 2.26).204
 M. kansasii7.31 (−17.3, 32.0).5606.34 (−11.1, 23.8).474
Spirometry
 FEV1, L3.84 (−4.77, 12.4).3813.80 (−2.01, 9.62).199
 FVC, L9.26 (2.64, 15.9).0062.29 (−2.31, 6.90).327
 DLCO, %.23 (.08, .38).003.16 (.06, .26).001

Abbreviations: CI, confidence interval; DLCO, diffusing capacity of carbon monoxide; FEV1, forced expiratory volume in 1 second; FVC, forced vital capacity.

Table 3.
Open in new tab

Factors Associated With Physical Functioning and Respiratory Symptoms at the Time of Treatment Initiation

Physical FunctioningRespiratory Symptoms
Coefficient (95% CI)PCoefficient (95% CI)P
Radiographic type
 Nodular bronchiectaticReferenceReference
 Fibrocavitary−6.16 (−13.5, 1.18).100−2.44 (−7.52, 2.63).344
 Other−6.00 (−16.2, 4.22).249−4.58 (−11.7, 2.51).205
Mycobacterial species
 M. aviumReferenceReference
 M. intracellulare2.73 (−2.78, 8.25).3300.18 (−3.73, 4.08).930
 M. abscessus−2.21 (−10.4, 5.96).594−1.97 (−7.73, 3.79).501
 M. massiliense−5.15 (−14.2, 3.88).263−4.14 (−10.5, 2.26).204
 M. kansasii7.31 (−17.3, 32.0).5606.34 (−11.1, 23.8).474
Spirometry
 FEV1, L3.84 (−4.77, 12.4).3813.80 (−2.01, 9.62).199
 FVC, L9.26 (2.64, 15.9).0062.29 (−2.31, 6.90).327
 DLCO, %.23 (.08, .38).003.16 (.06, .26).001
Physical FunctioningRespiratory Symptoms
Coefficient (95% CI)PCoefficient (95% CI)P
Radiographic type
 Nodular bronchiectaticReferenceReference
 Fibrocavitary−6.16 (−13.5, 1.18).100−2.44 (−7.52, 2.63).344
 Other−6.00 (−16.2, 4.22).249−4.58 (−11.7, 2.51).205
Mycobacterial species
 M. aviumReferenceReference
 M. intracellulare2.73 (−2.78, 8.25).3300.18 (−3.73, 4.08).930
 M. abscessus−2.21 (−10.4, 5.96).594−1.97 (−7.73, 3.79).501
 M. massiliense−5.15 (−14.2, 3.88).263−4.14 (−10.5, 2.26).204
 M. kansasii7.31 (−17.3, 32.0).5606.34 (−11.1, 23.8).474
Spirometry
 FEV1, L3.84 (−4.77, 12.4).3813.80 (−2.01, 9.62).199
 FVC, L9.26 (2.64, 15.9).0062.29 (−2.31, 6.90).327
 DLCO, %.23 (.08, .38).003.16 (.06, .26).001

Abbreviations: CI, confidence interval; DLCO, diffusing capacity of carbon monoxide; FEV1, forced expiratory volume in 1 second; FVC, forced vital capacity.

Close
This Feature Is Available To Subscribers Only

Sign In or Create an Account

Close

This PDF is available to Subscribers Only

View Article Abstract & Purchase Options

For full access to this pdf, sign in to an existing account, or purchase an annual subscription.

Close